The global dietary supplements market size is expected to hit around USD 317.04 billion by 2030 and progressing a CAGR of 8.4% over the forecast period 2022 to 2030.
The on dietary
supplements Market, which provides a business strategy, research &
development activities, concise outline of the market valuation, valuable
insights pertaining to market share, size, supply chain analysis, competitive
landscape and regional proliferation of this industry.
Download
Free Sample@ https://www.precedenceresearch.com/sample/1211
Report Scope of the Dietary Supplements Market
| Report Highlights | Details |
| Market Size | US$ 317.04 Billion by 2030 |
| Growth Rate | CAGR of 8.4% From 2022 to 2030 |
| Base Year | 2022 |
| Historic Data | 2017 to 2021 |
| Forecast Period | 2023 to 2030 |
| Segments Covered | By Ingredient, By Form, By Application, By End User, By Type, By Distribution Channel and By Function |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
A recent
report provides crucial insights along with application based and forecast
information in the Global Dietary supplements Market. The report provides a
comprehensive analysis of key factors that are expected to drive the growth of
this market. This study also provides a detailed overview of the opportunities
along with the current trends observed in the Dietary supplements market.
A
quantitative analysis of the industry is compiled for a period of 10 years in
order to assist players to grow in the market. Insights on specific revenue
figures generated are also given in the report, along with projected revenue at
the end of the forecast period.
Companies
and Manufacturers Covered
The study
covers key players operating in the market along with prime schemes and
strategies implemented by each player to hold high positions in the industry.
Such a tough vendor landscape provides a competitive outlook of the industry,
consequently existing as a key insight. These insights were thoroughly analysed
and prime business strategies and products that offer high revenue generation
capacities were identified. Key players of the global Dietary supplements
market are included as given below:
Dietary supplements Market Key Players
- Bayer
- NBTY Inc
- Bionova Lifesciences
- Nu Skin Enterprises
- Carlyle Group
- Pfizer
- Arkopharma Laboratoires Pharmaceutiques
- Glanbia
- Herbalife International
- Abbott Laboratories
- GlaxoSmithKline
- Nature’s Sunshine Forms
- Amway
- Archer Daniels Midland
Market Segments
- Vitamins
- Minerals
- Fibers & Specialty Carbohydrates
- Omega Fatty Acids
- Botanicals
- Proteins & Amino Acids
- Others
By Form
- Capsules
- Tablets
- Gummies
- Soft gels
- Liquids
- Powders
- Others
By Application
- Energy & Weight Management
- Bone & Joint Health
- Diabetes
- General Health
- Immunity
- Cardiac Health
- Gastrointestinal Health
- Anti-cancer
- Lungs Detox/Cleanse
- Sexual Health
- Brain/Mental Health
- Skin/Hair/Nails
- Insomnia
- Anti-aging
- Menopause
- Prenatal Health
- Others
By End User
- Adults
- Geriatric
- Pregnant Women
- Children
- Infants
By Type
- OTC
- Prescribed
By Distribution Channel
- Offline
- Hypermarkets/Supermarkets
- Pharmacies
- Specialty Stores
- Practioner
- Others
- Online
By Function
- Additional supplements
- Medicinal supplements
- Sports nutrition
By Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- United Kingdom
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of Middle East & Africa
Report Objectives
- To define, describe, and forecast the global dietary
supplements market based on product, and region
- To provide detailed information regarding the major
factors influencing the growth of the market (drivers, opportunities, and
industry-specific challenges)
- To strategically analyze micromarkets1 with respect to
individual growth trends, future prospects, and contributions to the total
market
- To analyze opportunities in the market for stakeholders
and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to
four main regions—North America,
Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively
analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as
acquisitions, expansions, new product launches, and partnerships in the dietary
supplements market
Table of Content
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Dietary Supplements Market, By Ingredient
7.1. Dietary Supplements Market, by Ingredient, 2023-2032
7.1.1. Vitamins
7.1.1.1. Market Revenue and Forecast (2023-2032)
7.1.2. Minerals
7.1.2.1. Market Revenue and Forecast (2023-2032)
7.1.3. Fibers & Specialty Carbohydrates
7.1.3.1. Market Revenue and Forecast (2023-2032)
7.1.4. Omega Fatty Acids
7.1.4.1. Market Revenue and Forecast (2023-2032)
7.1.5. Botanicals
7.1.5.1. Market Revenue and Forecast (2023-2032)
7.1.6. Proteins & Amino Acids
7.1.6.1. Market Revenue and Forecast (2023-2032)
7.1.7. Others
7.1.7.1. Market Revenue and Forecast (2023-2032)
Chapter 8. Global Dietary Supplements Market, By Form
8.1. Dietary Supplements Market, by Form, 2023-2032
8.1.1. Capsules
8.1.1.1. Market Revenue and Forecast (2023-2032)
8.1.2. Tablets
8.1.2.1. Market Revenue and Forecast (2023-2032)
8.1.3. Gummies
8.1.3.1. Market Revenue and Forecast (2023-2032)
8.1.4. Soft gels
8.1.4.1. Market Revenue and Forecast (2023-2032)
8.1.5. Liquids
8.1.5.1. Market Revenue and Forecast (2023-2032)
8.1.6. Powders
8.1.6.1. Market Revenue and Forecast (2023-2032)
8.1.7. Others
8.1.7.1. Market Revenue and Forecast (2023-2032)
Chapter 9. Global Dietary Supplements Market, By Application
9.1. Dietary Supplements Market, by Application, 2023-2032
9.1.1. Energy & Weight Management
9.1.1.1. Market Revenue and Forecast (2023-2032)
9.1.2. Bone & Joint Health
9.1.2.1. Market Revenue and Forecast (2023-2032)
9.1.3. Diabetes
9.1.3.1. Market Revenue and Forecast (2023-2032)
9.1.4. General Health
9.1.4.1. Market Revenue and Forecast (2023-2032)
9.1.5. Immunity
9.1.5.1. Market Revenue and Forecast (2023-2032)
9.1.6. Cardiac Health
9.1.6.1. Market Revenue and Forecast (2023-2032)
9.1.7. Gastrointestinal Health
9.1.7.1. Market Revenue and Forecast (2023-2032)
9.1.8. Anti-cancer
9.1.8.1. Market Revenue and Forecast (2023-2032)
9.1.9. Lungs Detox/Cleanse
9.1.9.1. Market Revenue and Forecast (2023-2032)
9.1.10. Sexual Health
9.1.10.1. Market Revenue and Forecast (2023-2032)
9.1.11. Brain/Mental Health
9.1.11.1. Market Revenue and Forecast (2023-2032)
9.1.12. Skin/Hair/Nails
9.1.12.1. Market Revenue and Forecast (2023-2032)
9.1.13. Insomnia
9.1.13.1. Market Revenue and Forecast (2023-2032)
9.1.14. Anti-aging
9.1.14.1. Market Revenue and Forecast (2023-2032)
9.1.15. Menopause
9.1.15.1. Market Revenue and Forecast (2023-2032)
9.1.16. Prenatal Health
9.1.16.1. Market Revenue and Forecast (2023-2032)
9.1.17. Others
9.1.17.1. Market Revenue and Forecast (2023-2032)
Chapter 10. Global Dietary Supplements Market, By End User
10.1. Dietary Supplements Market, by End User, 2023-2032
10.1.1. Adults
10.1.1.1. Market Revenue and Forecast (2023-2032)
10.1.2. Geriatric
10.1.2.1. Market Revenue and Forecast (2023-2032)
10.1.3. Pregnant Women
10.1.3.1. Market Revenue and Forecast (2023-2032)
10.1.4. Children
10.1.4.1. Market Revenue and Forecast (2023-2032)
10.1.5. Infants
10.1.5.1. Market Revenue and Forecast (2023-2032)
Chapter 11. Global Dietary Supplements Market, By Type
11.1. Dietary Supplements Market, by Type, 2023-2032
11.1.1. OTC
11.1.1.1. Market Revenue and Forecast (2023-2032)
11.1.2. Prescribed
11.1.2.1. Market Revenue and Forecast (2023-2032)
Chapter 12. Global Dietary Supplements Market, By Distribution Channel
12.1. Dietary Supplements Market, by Distribution Channel, 2023-2032
12.1.1. Offline
12.1.1.1. Market Revenue and Forecast (2023-2032)
12.1.2. Hypermarkets/Supermarkets
12.1.2.1. Market Revenue and Forecast (2023-2032)
12.1.3. Pharmacies
12.1.3.1. Market Revenue and Forecast (2023-2032)
12.1.4. Specialty Stores
12.1.4.1. Market Revenue and Forecast (2023-2032)
12.1.5. Practioner
12.1.5.1. Market Revenue and Forecast (2023-2032)
12.1.6. Others
12.1.6.1. Market Revenue and Forecast (2023-2032)
12.1.7. Online
12.1.7.1. Market Revenue and Forecast (2023-2032)
Chapter 13. Global Dietary Supplements Market, By Function
13.1. Dietary Supplements Market, by Function, 2023-2032
13.1.1. Additional supplements
13.1.1.1. Market Revenue and Forecast (2023-2032)
13.1.2. Medicinal supplements
13.1.2.1. Market Revenue and Forecast (2023-2032)
13.1.3. Sports nutrition
13.1.3.1. Market Revenue and Forecast (2023-2032)
Chapter 14. Global Dietary Supplements Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Ingredient (2023-2032)
14.1.2. Market Revenue and Forecast, by Form (2023-2032)
14.1.3. Market Revenue and Forecast, by Application (2023-2032)
14.1.4. Market Revenue and Forecast, by End User (2023-2032)
14.1.5. Market Revenue and Forecast, by Type (2023-2032)
14.1.6. Market Revenue and Forecast, by Function (2023-2032)
14.1.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)
14.1.8. U.S.
14.1.8.1. Market Revenue and Forecast, by Ingredient (2023-2032)
14.1.8.2. Market Revenue and Forecast, by Form (2023-2032)
14.1.8.3. Market Revenue and Forecast, by Application (2023-2032)
14.1.8.4. Market Revenue and Forecast, by End User (2023-2032)
14.1.8.5. Market Revenue and Forecast, by Type (2023-2032)
14.1.8.6. Market Revenue and Forecast, by Function (2023-2032)
14.1.8.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Ingredient (2023-2032)
14.1.9.2. Market Revenue and Forecast, by Form (2023-2032)
14.1.9.3. Market Revenue and Forecast, by Application (2023-2032)
14.1.9.4. Market Revenue and Forecast, by End User (2023-2032)
14.1.9.5. Market Revenue and Forecast, by Type (2023-2032)
14.1.9.6. Market Revenue and Forecast, by Function (2023-2032)
14.1.9.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)
14.2. Europe
14.2.1. Market Revenue and Forecast, by Ingredient (2023-2032)
14.2.2. Market Revenue and Forecast, by Form (2023-2032)
14.2.3. Market Revenue and Forecast, by Application (2023-2032)
14.2.4. Market Revenue and Forecast, by End User (2023-2032)
14.2.5. Market Revenue and Forecast, by Type (2023-2032)
14.2.6. Market Revenue and Forecast, by Function (2023-2032)
14.2.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Ingredient (2023-2032)
14.2.8.2. Market Revenue and Forecast, by Form (2023-2032)
14.2.8.3. Market Revenue and Forecast, by Application (2023-2032)
14.2.8.4. Market Revenue and Forecast, by End User (2023-2032)
14.2.8.5. Market Revenue and Forecast, by Type (2023-2032)
14.2.8.6. Market Revenue and Forecast, by Function (2023-2032)
14.2.8.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)
14.2.9. Germany
14.2.9.1. Market Revenue and Forecast, by Ingredient (2023-2032)
14.2.9.2. Market Revenue and Forecast, by Form (2023-2032)
14.2.9.3. Market Revenue and Forecast, by Application (2023-2032)
14.2.9.4. Market Revenue and Forecast, by End User (2023-2032)
14.2.9.5. Market Revenue and Forecast, by Type (2023-2032)
14.2.9.6. Market Revenue and Forecast, by Function (2023-2032)
14.2.9.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)
14.2.10. France
14.2.10.1. Market Revenue and Forecast, by Ingredient (2023-2032)
14.2.10.2. Market Revenue and Forecast, by Form (2023-2032)
14.2.10.3. Market Revenue and Forecast, by Application (2023-2032)
14.2.10.4. Market Revenue and Forecast, by End User (2023-2032)
14.2.10.5. Market Revenue and Forecast, by Type (2023-2032)
14.2.10.6. Market Revenue and Forecast, by Function (2023-2032)
14.2.10.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)
14.2.11. Rest of Europe
14.2.11.1. Market Revenue and Forecast, by Ingredient (2023-2032)
14.2.11.2. Market Revenue and Forecast, by Form (2023-2032)
14.2.11.3. Market Revenue and Forecast, by Application (2023-2032)
14.2.11.4. Market Revenue and Forecast, by End User (2023-2032)
14.2.11.5. Market Revenue and Forecast, by Type (2023-2032)
14.2.11.6. Market Revenue and Forecast, by Function (2023-2032)
14.2.11.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Ingredient (2023-2032)
14.3.2. Market Revenue and Forecast, by Form (2023-2032)
14.3.3. Market Revenue and Forecast, by Application (2023-2032)
14.3.4. Market Revenue and Forecast, by End User (2023-2032)
14.3.5. Market Revenue and Forecast, by Type (2023-2032)
14.3.6. Market Revenue and Forecast, by Function (2023-2032)
14.3.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)
14.3.8. India
14.3.8.1. Market Revenue and Forecast, by Ingredient (2023-2032)
14.3.8.2. Market Revenue and Forecast, by Form (2023-2032)
14.3.8.3. Market Revenue and Forecast, by Application (2023-2032)
14.3.8.4. Market Revenue and Forecast, by End User (2023-2032)
14.3.8.5. Market Revenue and Forecast, by Type (2023-2032)
14.3.8.6. Market Revenue and Forecast, by Function (2023-2032)
14.3.8.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)
14.3.9. China
14.3.9.1. Market Revenue and Forecast, by Ingredient (2023-2032)
14.3.9.2. Market Revenue and Forecast, by Form (2023-2032)
14.3.9.3. Market Revenue and Forecast, by Application (2023-2032)
14.3.9.4. Market Revenue and Forecast, by End User (2023-2032)
14.3.9.5. Market Revenue and Forecast, by Type (2023-2032)
14.3.9.6. Market Revenue and Forecast, by Function (2023-2032)
14.3.9.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)
14.3.10. Japan
14.3.10.1. Market Revenue and Forecast, by Ingredient (2023-2032)
14.3.10.2. Market Revenue and Forecast, by Form (2023-2032)
14.3.10.3. Market Revenue and Forecast, by Application (2023-2032)
14.3.10.4. Market Revenue and Forecast, by End User (2023-2032)
14.3.10.5. Market Revenue and Forecast, by Type (2023-2032)
14.3.10.6. Market Revenue and Forecast, by Function (2023-2032)
14.3.10.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)
14.3.11. Rest of APAC
14.3.11.1. Market Revenue and Forecast, by Ingredient (2023-2032)
14.3.11.2. Market Revenue and Forecast, by Form (2023-2032)
14.3.11.3. Market Revenue and Forecast, by Application (2023-2032)
14.3.11.4. Market Revenue and Forecast, by End User (2023-2032)
14.3.11.5. Market Revenue and Forecast, by Type (2023-2032)
14.3.11.6. Market Revenue and Forecast, by Function (2023-2032)
14.3.11.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Ingredient (2023-2032)
14.4.2. Market Revenue and Forecast, by Form (2023-2032)
14.4.3. Market Revenue and Forecast, by Application (2023-2032)
14.4.4. Market Revenue and Forecast, by End User (2023-2032)
14.4.5. Market Revenue and Forecast, by Type (2023-2032)
14.4.6. Market Revenue and Forecast, by Function (2023-2032)
14.4.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)
14.4.8. GCC
14.4.8.1. Market Revenue and Forecast, by Ingredient (2023-2032)
14.4.8.2. Market Revenue and Forecast, by Form (2023-2032)
14.4.8.3. Market Revenue and Forecast, by Application (2023-2032)
14.4.8.4. Market Revenue and Forecast, by End User (2023-2032)
14.4.8.5. Market Revenue and Forecast, by Type (2023-2032)
14.4.8.6. Market Revenue and Forecast, by Function (2023-2032)
14.4.8.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)
14.4.9. North Africa
14.4.9.1. Market Revenue and Forecast, by Ingredient (2023-2032)
14.4.9.2. Market Revenue and Forecast, by Form (2023-2032)
14.4.9.3. Market Revenue and Forecast, by Application (2023-2032)
14.4.9.4. Market Revenue and Forecast, by End User (2023-2032)
14.4.9.5. Market Revenue and Forecast, by Type (2023-2032)
14.4.9.6. Market Revenue and Forecast, by Function (2023-2032)
14.4.9.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)
14.4.10. South Africa
14.4.10.1. Market Revenue and Forecast, by Ingredient (2023-2032)
14.4.10.2. Market Revenue and Forecast, by Form (2023-2032)
14.4.10.3. Market Revenue and Forecast, by Application (2023-2032)
14.4.10.4. Market Revenue and Forecast, by End User (2023-2032)
14.4.10.5. Market Revenue and Forecast, by Type (2023-2032)
14.4.10.6. Market Revenue and Forecast, by Function (2023-2032)
14.4.10.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)
14.4.11. Rest of MEA
14.4.11.1. Market Revenue and Forecast, by Ingredient (2023-2032)
14.4.11.2. Market Revenue and Forecast, by Form (2023-2032)
14.4.11.3. Market Revenue and Forecast, by Application (2023-2032)
14.4.11.4. Market Revenue and Forecast, by End User (2023-2032)
14.4.11.5. Market Revenue and Forecast, by Type (2023-2032)
14.4.11.6. Market Revenue and Forecast, by Function (2023-2032)
14.4.11.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Ingredient (2023-2032)
14.5.2. Market Revenue and Forecast, by Form (2023-2032)
14.5.3. Market Revenue and Forecast, by Application (2023-2032)
14.5.4. Market Revenue and Forecast, by End User (2023-2032)
14.5.5. Market Revenue and Forecast, by Type (2023-2032)
14.5.6. Market Revenue and Forecast, by Function (2023-2032)
14.5.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)
14.5.8. Brazil
14.5.8.1. Market Revenue and Forecast, by Ingredient (2023-2032)
14.5.8.2. Market Revenue and Forecast, by Form (2023-2032)
14.5.8.3. Market Revenue and Forecast, by Application (2023-2032)
14.5.8.4. Market Revenue and Forecast, by End User (2023-2032)
14.5.8.5. Market Revenue and Forecast, by Type (2023-2032)
14.5.8.6. Market Revenue and Forecast, by Function (2023-2032)
14.5.8.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Ingredient (2023-2032)
14.5.9.2. Market Revenue and Forecast, by Form (2023-2032)
14.5.9.3. Market Revenue and Forecast, by Application (2023-2032)
14.5.9.4. Market Revenue and Forecast, by End User (2023-2032)
14.5.9.5. Market Revenue and Forecast, by Type (2023-2032)
14.5.9.6. Market Revenue and Forecast, by Function (2023-2032)
14.5.9.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)
Chapter 15. Company Profiles
15.1. Bayer
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. NBTY Inc
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Bionova Lifesciences
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Nu Skin Enterprises
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Carlyle Group
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Pfizer
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Arkopharma Laboratoires Pharmaceutiques
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Glanbia
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Herbalife International
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Abbott Laboratories
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments